From July 1, 2025, according to the provisions of Circular 02/2018/TT-BYT, Circular 03/2018/TT-BYT (amended and supplemented in Circular 11/2025/TT-BYT), pharmaceutical businesses that have been granted a certificate of eligibility for business must have a written notice to the provincial health professional agency before starting or terminating operations via e-commerce. The notification dossier is implemented according to form No. 05/GPP and form No. 06/GPP with the appendix of the Circular.
However, up to now, there have been no drug retail establishments and drug and pharmaceutical ingredient wholesale establishments in Ho Chi Minh City that have notified the Department of Health about operating via e-commerce.
In order to ensure pharmaceutical business via e-commerce in the city, the Department of Industry and Trade of Ho Chi Minh City has sent a document to relevant units, requesting strict implementation of regulations when doing pharmaceutical business via e-commerce.
Traders and organizations providing e-commerce services, including online exchanges and promotional websites, are responsible for guiding pharmaceutical sellers to fully fulfill their obligations according to regulations.
Units must closely coordinate with state management agencies to ensure the quality of drugs in circulation, as well as the legitimate rights of consumers.
Regularly review and request sellers to supplement records and documents proving eligibility for pharmaceutical business before allowing them to operate on the platform; promptly warn or apply measures to temporarily or permanently refuse to provide services to traders, organizations and individuals who violate the law in pharmaceutical business activities.
Tightening management is expected to create a transparent business environment, limit the situation of drugs of unknown origin, and protect the health and rights of people when buying drugs on digital platforms.
